5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents

This publication has 9 references indexed in Scilit:

• Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices
  Published by Elsevier ,2002
• Antidepressant interactions with 5-hydroxytryptamine3 receptor binding sites
  European Journal of Pharmacology, 1989
• Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity
  Journal of Neuroscience, 1988
• Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites
  European Journal of Pharmacology, 1988
• New Data Intensify the Agony Over Ecstasy
  Science, 1988
• Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain
  Biochemical Pharmacology, 1987
• [3H]3,4-Methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paper
  European Journal of Pharmacology, 1987
• In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
  Biochemical Pharmacology, 1987
• NEUROTOXICITY OF THE PSYCHEDELIC AMPHETAMINE, METHYLENEDIOXYMETHAMPHETAMINE
  1987